Public Policy
In the wake of the Supreme Court decision on Rutledge vs. PCMA, states have introduced legislation threatening ERISA pre-emption for employer-sponsored health plans. More
Briefing
“Legislation”
19 result(s)
Public Policy
ACA Returns to Court
The California vs. Texas case before the U.S. Supreme Court could help determine the future of the Affordable Care Act (ACA), and could lead to one of several different results. More
Commentary
Public Policy
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity... More
Commentary
Public Policy
With a slate of bills trying to tackle rising drug prices, CVS Health advocates for those that could help increase competition and lower drug prices; others may limit private... More
Commentary
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently... More
Briefing
Government Programs and Services
CVS Health undertook an enterprise-wide initiative to ensure 13M Medicare beneficiaries had a smooth transition to new MBI cards. More
Commentary
Cost Management
CVS Health responded to the Administration's Blueprint on lowering drug costs and highlighted what the company does to control costs. We also recommended things the... More
Commentary
Public Policy
As health care costs continue to rise and demand for primary care providers outpaces supply, pharmacists are increasingly on the front lines of care utilizing their clinical... More
Commentary
Public Policy
This fall, as state legislatures reconvene, they’ll consider dozens of bills aimed at restricting PBM tools like utilization management that help control costs while ensuring... More
Commentary
Government Programs and Services
Despite lack of consistent national standards, payors can earn meaningful incentives for improvements to Medicaid quality measures. More
Briefing